Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Gianello, Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone, Horm
Furthermore, with continued use, the formula may help support the skins natural barrier and resilience against external environmental stressors
Sleep apnea considerations : While weight loss typically improves obstructive sleep apnea (OSA), symptoms may persist despite weight reduction
It'll be subtle, it won't be dramatic, it won't be like earth-shattering change, it's not going to grow hair for sure, you know, look at me